Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05369234 · ClinicalTrials.gov registry record · Phase 3
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
A Phase 3 study of Esophageal Cancer and Oropharynx Cancer, sponsored by Covenant Health Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05369234 is a Phase 3 study of Esophageal Cancer and Oropharynx Cancer that has completed, run by Covenant Health Cancer Center. The registered enrollment target is 100 participants, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05369234, a Phase 3 study of Esophageal Cancer and Oropharynx Cancer, has completed, sponsored by Covenant Health Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
As mentioned above, several prior studies have shown the positive effects of oral use of aloe vera juice in managing chemotherapy and radiation-induced oral mucositis and esophagitis. This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and esophagitis. The intention is to determine whether aloe vera juice should be considered as part of standard treatment.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 100% Aloe Vera Juice
- COMBINATION_PRODUCT Magic Mouthwash
- COMBINATION_PRODUCT Salt and Baking soda rinse
- DRUG Carafate
Study Locations (1)
Tennessee
- Thompson Cancer Survival Center Radiation Oncology Services - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2024-01-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05369234
The ClinicalTrials.gov registry entry for NCT05369234 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Covenant Health Cancer Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 4 interventions - of which 100% Aloe Vera Juice is the first listed.
NCT05369234 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05369234 about?
NCT05369234 is a clinical study titled "Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis". As mentioned above, several prior studies have shown the positive effects of oral use of aloe vera juice in managing chemotherapy and radiation-induced oral mucositis and esophagitis. This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and...
What is the current status of trial NCT05369234?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2022-01-20. Estimated completion is 2024-01-30.
What conditions does trial NCT05369234 study?
This clinical trial studies the following conditions: Esophageal Cancer, Oropharynx Cancer, Oral Cavity Cancer, Laryngeal Cancer, Head and Neck Cancers - Tonsils.
What interventions are being tested in trial NCT05369234?
The interventions under investigation include: 100% Aloe Vera Juice (DIETARY_SUPPLEMENT), Magic Mouthwash (COMBINATION_PRODUCT), Salt and Baking soda rinse (COMBINATION_PRODUCT), Carafate (DRUG).
Who is sponsoring clinical trial NCT05369234?
This trial is sponsored by Covenant Health Cancer Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05369234 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
RECRUITING · Phase 3
-
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RECRUITING · Phase 3
-
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
COMPLETED · Phase 3
-
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
COMPLETED · Phase 3
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.